ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XRTX Xortx Therapeutics Inc

3.65
0.25 (7.35%)
May 03 2024 - Closed
Delayed by 15 minutes

Xortx Therapeutics Financial Summary

The current XRTX market cap is 7.29M. The company's latest EPS is CAD -1.0801 and P/E is -2.48.

Year End December 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income -368k-1.14M-2.42M-12.33M-5.53M
Net Income -629k-1.28M-1.65M-9.49M-2.16M
Year End December 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 1.09M2.29M22.04M16.75M5.47M
Total Liabilities 1.3M1.03M5.3M7.29M826k
Total Equity -211k1.26M16.74M9.47M4.64M

Cash Flow

Year End December 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -249k-728k-6.06M-11.97M-6.58M
Investing -7k-14k-40k-60k-46k
Financing 55k855k24.46M6.43M-361k
Market Cap 7.29M
Price to Earnings Ratio -2.48
Price to Sales Ratio 0
Price to Cash Ratio 1.55
Price to Book Ratio 1.15
Dividend Yield -

Share Statistics

Shares Outstanding 2M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.07 (1.89%)

Company Info

Company Name Xortx Therapeutics Inc
Address 550 burrard street, suite 2900
vancouver, british columbia V6C OA3
Website https://www.xortx.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock